Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-01

FDA Approved: MESALAMINE — Supplemental Application (Sun Pharmaceutical Industries Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical Industries' supplemental application for Mesalamine, confirming regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)